Cargando…
Combination of Intravitreal Bevacizumab and Peripheral Photocoagulation: An Alternative Treatment in Eales Disease
To report the efficacy of combination therapy (bevacizumab and photocoagulation) in a case of Eales Disease this study has been performed. Bevacizumab (Avastin, 1.25 mg/0.05 ml) was injected intravitreously for the treatment of iris and retinal neovascularization in a 56-year old Hispanic female wit...
Autores principales: | CP, Juarez, AL, Gramajo, JD, Luna |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Medical Hypothesis, Discovery & Innovation Ophthalmology
2013
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3939753/ https://www.ncbi.nlm.nih.gov/pubmed/24600639 |
Ejemplares similares
-
Role of Intravitreal Bevacizumab in Management of Eale’s Disease
por: Mehboob, Mohammad Asim, et al.
Publicado: (2018) -
Intravitreal bevacizumab as an adjunct to vitrectomy in advanced Eales’ disease
por: Thakar, Meenakshi, et al.
Publicado: (2011) -
Adjuvant Intravitreal Bevacizumab for Retinal Neovascularization in Eales’ Disease Associated With Latent Mycobacterium Tuberculosis
por: Gonzalez Martinez, Orlando G, et al.
Publicado: (2023) -
Efficacy of intravitreal bevacizumab combined with pan retinal photocoagulation versus panretinal photocoagulation alone in treatment of proliferative diabetic retinopathy
por: Sameen, Murtaza, et al.
Publicado: (2017) -
Intravitreal Bevacizumab Alone versus Combined with Macular Photocoagulation in Diabetic Macular Edema
por: Lee, Soo Jeong, et al.
Publicado: (2011)